Rockwell Medical, Inc. provided earnings guidance for the year 2024. For the year, the company expects Net (Product) Sales of $84.0 million to $88.0 million, 5% to 10% increase over $79.8 million in product sales for 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 USD | -0.68% | -4.58% | -22.76% |
Apr. 17 | Rockwell Medical Continues to Expand Its Distribution Capabilities in Western United States | CI |
Apr. 04 | Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.76% | 43.46M | |
+32.18% | 664B | |
+29.29% | 567B | |
-7.08% | 354B | |
+19.46% | 330B | |
+4.49% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-5.16% | 148B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Rockwell Medical, Inc. Provides Earnings Guidance for the Year 2024